Akelos
is a New York-based biopharmaceutical company that researches and develops non-narcotic drugs for the treatment of neuropathic conditions... Read moreAkelos
is a New York-based biopharmaceutical company that researches and develops non-narcotic drugs for the treatment of neuropathic conditions... Read more
News
Apr 16, 2025
EIN Presswire
Press Release: Akelos : Akelos Receives Australian Patent Allowance on Lead Compound, AKE-1018
Jan 29, 2025
EIN Presswire
Press Release: Akelos : Akelos Inc. Receives Chinese Patent For Its Lead Compound
Jan 10, 2025
EIN Presswire
Press Release: Akelos : AKELOS INC RECEIVES USPTO RENEWAL OF TRADEMARK
Oct 11, 2024
EIN Presswire
Press Release: Akelos : Akelos Inc. Announces Japan Patent Office Allowance Of Patent Claiming its Lead Compound
Jun 04, 2024
EIN Presswire
Press Release: Akelos : Scott L. Dax, MS, PhD, Research and Development Champion, Joins Scientific Advisory Board of Akelos Inc.
Feb 15, 2023
EIN Presswire
Press Release: Akelos : Akelos Inc. Announces United States Patent and Trademark Office Allowance of Patent Claiming its Lead Compound
Feb 01, 2023
Newswire
Press Release: Akelos : Darryle D. Schoepp, Ph.D., Former Merck and Eli Lilly Executive, Joins Scientific Advisory Board of Akelos Inc., Biotechnology Company Developing Opioid Alternatives
Oct 26, 2022
Newswire
Press Release: Akelos : Akelos Inc. Receives STTR Grant From NINDS
Mar 04, 2021
ePRNews
Press Release: Akelos : Akelos Inc.'s Lead Compound Achieves Preclinical Safety Milestone
Feb 05, 2021
ePRNews
Press Release: Akelos : Akelos Inc.'s SAB Member Co-Authors Paper Validating HCN1 as a Therapeutic Target for the Treatment of Peripheral Neuropathic Pain
Akelos Competitors
1
2
3
4
5
6
7
8
9
10